News

Tethis Acquires See.d Platform from MACS, Taps Everex to Scale Production

Milan – September 21, 2026 -- Tethis S.p.A. has completed the acquisition of the See.d software and engineering business unit from MACS S.r.l., gaining full control over intellectual property and engineering know-how behind its liquid biopsy platform. Alongside the transfer, Tethis signed a long-term manufacturing and supply agreement with Everex S.r.l., an Italian in-vitro diagnostic instrumentation maker, to handle production and future scale-up of the system.

Tethis consolidates full ownership of its liquid biopsy pre-analytical platform

See.d is the cornerstone of Tethis' liquid biopsy workflow, developed jointly with MACS to standardize pre-analytical blood processing. From a single blood sample, the platform generates plasma for cfDNA analysis and cytology slides preserving nucleated cells for downstream characterization, automating plasma separation, red blood cell lysis, and deposition onto Tethis' proprietary SmartBioSurface slides.

Hackensack Meridian CEO Robert Garrett to Retire June 2027

Iselin, N.J. – September 21, 2026 -- Hackensack Meridian Health's Board of Trustees announced that CEO Robert C. Garrett will retire effective June 30, 2027, ending a tenure that built New Jersey's largest health network from the ground up. A national search for his successor is now underway, with the Board targeting a decision by the end of the first quarter of 2027.

Network expanded to 18 hospitals and 41,000 employees over ten years

Since HMH's creation a decade ago, the system has grown to 18 hospitals, 41,000 team members and more than 500 patient care locations across New Jersey — nearly triple its size at launch. Under Garrett, the network also opened the Hackensack Meridian School of Medicine, the state's first new private medical school in decades, alongside a new discovery research center.

Zenoti CEO Publishes Growth Playbook From 42 Beauty, Wellness Leaders

Seattle – September 21, 2026 -- Sudheer Koneru, CEO and founder of Zenoti, unveiled a new book, Growth Diaries: How the Best Beauty and Wellness Brands Scale from 1 Store to 100+, drawing on interviews with 42 founders, CEOs, and industry leaders across nine countries.

Book maps four growth phases for multi-unit beauty and wellness operators

Growth Diaries organizes the operators' experiences into four stages: the first store, the early chain, infrastructure, and institutional scale, providing a stage-by-stage framework for founders scaling service-based businesses. The book argues that beauty, wellness, and fitness brands face distinct scaling challenges compared to software, retail, or restaurant companies, since services are delivered live and an unfilled appointment cannot be recovered as revenue later.

Merry Life Advances TML-6 Into 210-Patient Global Alzheimer's Phase 2

Taipei – September 21, 2026 -- Merry Life Biomedical has advanced TML-6, a Taiwan-developed oral therapy for early Alzheimer's disease, into a global Phase 2 trial spanning 20 clinical sites across Taiwan, Sweden, and the United States, targeting approximately 210 participants.

Twenty sites across three countries anchor the trial's design

The study includes nine medical centers in Taiwan, seven sites in Sweden, and four centers in the United States, with Taiwan forming the largest single group of participating sites. The randomized, double-blind, placebo-controlled trial will assign patients to TML-6 100 mg, TML-6 200 mg, or placebo, administered once daily for 52 weeks.

Akeso's Ivonescimab Wins ESMO Late-Breaking Slot for Biliary Cancer Data

Hong Kong – September 21, 2026 -- Akeso, Inc. (9926.HK) will present nearly 30 clinical studies of its bispecific antibodies at the European Society for Medical Oncology (ESMO) Congress in Madrid on October 23-27, 2026, including a Late-Breaking Abstract selected for the Presidential Symposium.

Phase III biliary tract cancer trial secures Presidential Symposium slot

Overall survival results from the Phase III HARMONi-GI1 trial, comparing ivonescimab plus chemotherapy against durvalumab plus chemotherapy as a first-line treatment for advanced biliary tract cancer, will be delivered as a late-breaking oral presentation (LBA8) on October 25 at 16:30-18:15 in Madrid. The presentation will be given by Jian Zhou of Shanghai during Presidential Symposium II.

Kakao Pay, Kakao Bank Partner With Fireblocks on Korea Digital Assets

Seoul, South Korea – September 21, 2026 -- Kakao Pay and Kakao Bank have signed a memorandum of understanding with Fireblocks to build secure onchain infrastructure for Korea's emerging digital asset market, with stablecoins as an initial focus area.

Three parties will test stablecoin distribution frameworks through proof-of-concept trials

Under the agreement, Kakao Pay, Kakao Bank and Fireblocks will jointly explore business opportunities based on Korea's market conditions and infrastructure demand. The companies plan to design digital asset distribution frameworks tailored to Korea's regulatory, security, and service requirements, then run proof-of-concept tests to validate their applicability.

Ex-Denver Airport CEO Phillip Washington Joins HNTB as SVP

Denver – September 21, 2026 -- Phillip A. Washington, the former chief executive officer of Denver International Airport, has joined engineering firm HNTB Corporation as president of strategy and client service, markets and services, and senior vice president.

Washington brings leadership from three major U.S. transportation agencies to HNTB

Washington most recently ran Denver International Airport, one of the world's busiest airports, where he oversaw a multibillion-dollar capital improvement program targeting capacity, customer experience and safety. He previously served as CEO of the Los Angeles County Metropolitan Transportation Authority, leading an 11,000-person organization responsible for the largest modern public works program in North America, and earlier headed Denver's Regional Transportation District, where he delivered the FasTracks expansion program and the redevelopment of Denver Union Station.

Century Fasteners to Showcase Cherry Aerospace Line at Phoenix Expo

Elmhurst, N.Y. – September 21, 2026 -- Century Fasteners Corp. will exhibit at the 2026 International Fastener Expo in Phoenix, Arizona, from October 7-9, presenting its authorized distributor relationship with Cherry Aerospace at Booth 2756.

Century Fasteners expands aerospace fastener access through Cherry Aerospace distribution deal

Century Fasteners Corp., an authorized distributor for Cherry Aerospace, said the partnership broadens availability of Cherry's fastening systems to distributors and OEMs. Cherry Aerospace, headquartered in Santa Ana, California, is a member of the SPS Fastener Division of Precision Castparts Corp. and manufactures the CherryMax line of rivets, widely used across the aerospace industry alongside blind bolts, rivetless nut plates, shear pin fasteners and installation tools.

TMGM Extends Chelsea FC Partnership Into Fourth Year, Adds Middle East Rights

Sydney – September 21, 2026 -- TMGM Group has extended its sponsorship of Chelsea Football Club into a fourth year, expanding its regional rights to include the Middle East alongside its existing Asia-Pacific footprint.

TMGM branding appeared on Chelsea's FA Cup shirts for the first time in club history in 2026

The milestone marked the highest-profile moment yet in the three-year partnership. TMGM also joined Chelsea's 2026 Asia-Pacific Pre-Season Tour as an Official Partner, securing open training access, pitch-side presence and post-match tunnel experiences for clients.

i-80 Gold's Granite Creek Study Shows 556,500 oz Reserve, $118M NPV

Nevada – September 21, 2026 -- i-80 Gold Corp. has completed a feasibility study for its Granite Creek Underground project outlining initial proven and probable mineral reserves of 556,500 ounces of gold at 7.87 grams per tonne across 2.20 million tonnes.

Measured and indicated resources jump 229% versus March 2025 preliminary assessment

The updated mineral resource estimate shows measured and indicated resources rising to 3.73 million tonnes grading 7.17 g/t gold, containing 859,500 ounces, a 229% increase from the PEA published in March 2025. Inferred resources fell 38% to 0.89 million tonnes at 7.06 g/t gold (202,800 ounces) as infill drilling converted material into higher-confidence categories. The estimate incorporates roughly 36,470 meters of drilling from 164 core holes completed between 2023 and the end of 2025.

Subscribe to News